Chemotherapy for Prostate Cancer: a Shared Decision

This podcast is sponsored by Sanofi. Participants have been compensated and/or received an honorarium from Sanofi in connection with this podcast. This content was jointly developed by the participants and Sanofi. This is a promotional event and no CME credits are offered.

Healthcare providers face a communication challenge when it comes to talking about chemotherapy with their patients who have prostate cancer. This podcast, geared toward oncologists, primary physicians, and nurse practitioners, explores some of the myths and misconceptions men and their caregivers may have about chemotherapy as a treatment option for prostate cancer. Our experts provide tips for how to talk with patients about their fears, and they offer information to encourage shared decision making so that patients understand whether chemotherapy may be the right choice for prostate cancer.

Host
Pedro Barata, MD, MSc, associate professor and medical oncologist, Tulane Comprehensive Cancer Center

Guests
Rana McKay, MD, associate professor and medical oncologist, UC San Diego Health

Vivek Narayan, MD, MS, assistant professor of medicine, University of Pennsylvania; medical oncologist, Hospital of the University of Pennsylvania

©2023 sanofi-aventis U.S. LLC - All rights reserved.
MAT-US-2302472-v1.0-04/2023

Co-host

Dr. Rana McKay

Dr Rana McKay is associate professor at UC San Diego, Health School of Medicine and is a board-certified medical oncologist. She specializes in treating urogenital cancers and leads a multidisciplinary prostate cancer clinic for men who have aggressive prostate cancer. She has been a principal investigator for several clinical trials and has published numerous articles in leading peer-reviewed journals, such as Nature, Lancet, Journal of Clinical Oncology, and others. Her research focus includes novel biomarkers and therapeutic outcomes for patients who have genitourinary cancer.